A Single Arm Clinical Study on the Effects of Continuous Erythropoietin Receptor Activator Treatment in Non-Dialysis Patients with Chronic Heart Failure and Renal Anemia

Erythropoiesis-stimulating agents improve the NYHA functional class and decrease the hospital readmission rates for heart failure; however, little is known about the influence of continuous erythropoietin receptor activator (CERA) on the heart. Therefore, a prospective study was conducted to investi...

Full description

Bibliographic Details
Published in:Biomedicines
Main Authors: Akira Sezai, Hisakuni Sekino, Makoto Taoka, Shunji Osaka, Masashi Tanaka
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Subjects:
renal anemia
heart failure
erythropoietin
Online Access:https://www.mdpi.com/2227-9059/11/3/946

Internet

https://www.mdpi.com/2227-9059/11/3/946

Similar Items